Residency · Residency · Vascular Surgery
Diabetic Foot: Multidisciplinary Limb Preservation
Introduction
The diabetic foot represents one of the most complex challenges encountered in vascular surgery. Diabetes mellitus affects over 500 million people worldwide, and approximately 15% to 25% of these patients will develop a foot ulcer at some point in their lives. Complications arising from diabetic foot ulcers are the leading cause of non-traumatic lower extremity amputations. Achieving optimal outcomes in managing diabetic foot problems requires a multidisciplinary limb preservation team, integrating expertise from various specialties to address the multifaceted nature of this condition.
Pathophysiology
The Diabetic Triad
The pathophysiology of the diabetic foot is classically described by the "diabetic triad," which includes peripheral neuropathy, peripheral arterial disease (PAD), and immunopathy. Peripheral neuropathy involves sensory loss that eliminates protective sensation, motor neuropathy that causes intrinsic muscle wasting and foot deformities, and autonomic neuropathy that impairs sweating and microvascular regulation. Peripheral arterial disease in diabetes typically affects the tibial and peroneal arteries, with relative sparing of the foot arteries. Medial arterial calcification, common in diabetic PAD, often renders the ankle-brachial index (ABI) unreliable. Immunopathy in diabetes is characterized by impaired neutrophil function, defective chemotaxis, and poor glycemic control, all of which increase susceptibility to infection.
Biomechanical Factors
Motor neuropathy leads to deformities such as claw toe and hammer toe, which shift weight-bearing to the metatarsal heads. The loss of protective sensation allows repetitive trauma from ill-fitting footwear to go unnoticed. Charcot neuroarthropathy is an inflammatory destruction of the tarsal and metatarsal joints, resulting in a rocker-bottom deformity. These biomechanical changes increase plantar pressures at bony prominences, predisposing the foot to ulceration.
Assessment of the Diabetic Foot
Clinical Evaluation
A thorough neurologic examination is essential and includes testing with a 10-g Semmes-Weinstein monofilament, a 128-Hz tuning fork, and assessment of ankle reflexes. Vascular assessment involves palpation of pedal pulses, measurement of the ankle-brachial index (ABI), toe-brachial index (TBI), transcutaneous oxygen pressure (TcPO2), and duplex ultrasound imaging. Wound assessment utilizes the WIfI classification system, which evaluates Wound extent, Ischemia, and foot Infection. The probe-to-bone test is a valuable clinical tool; a positive result has an 89% positive predictive value for osteomyelitis. It is also important to assess for Charcot foot deformity and biomechanical malalignment.
Imaging
Weight-bearing radiographs are used to assess for osteomyelitis, fractures, gas gangrene, and Charcot changes. Magnetic resonance imaging (MRI) is the most sensitive and specific imaging modality for diagnosing osteomyelitis, with a sensitivity of 90% and specificity of 80%. When revascularization is being considered, CT angiography or MR angiography provides detailed vascular mapping. Nuclear medicine scans, such as tagged white blood cell scans, are useful when MRI is contraindicated.
Laboratory Evaluation
Laboratory tests include measurement of HbA1c and fasting glucose to assess glycemic control, as well as serum albumin and prealbumin to evaluate nutritional status. Complete blood count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) are used to assess for infection. Blood cultures should be obtained if systemic sepsis is suspected. Wound cultures are best obtained via deep tissue biopsy rather than superficial swabs to accurately identify pathogens.
The Multidisciplinary Team
Management of the diabetic foot requires a coordinated multidisciplinary team. Vascular surgeons are responsible for planning and performing revascularization procedures. Podiatrists provide biomechanical assessment, orthotics, offloading strategies, and minor surgical procedures. Endocrinologists focus on optimizing glycemic control. Infectious disease specialists guide antibiotic selection for complex infections and osteomyelitis. Orthopedic surgeons manage Charcot reconstruction and internal fixation. Wound care specialists apply advanced wound therapies, including negative pressure wound therapy. Orthotics and prosthetics professionals provide custom footwear and total contact casting. Physical therapists and rehabilitation specialists assist with gait training and fall prevention.
Management Strategy
Infection Control
Infection severity is classified according to the IDSA/IWGDF guidelines into mild, moderate, and severe categories. Mild infections are treated with oral antibiotics targeting gram-positive organisms. Moderate to severe infections require intravenous antibiotics with broad-spectrum coverage, including anaerobes. Urgent surgical debridement is indicated for abscesses, wet gangrene, necrotizing fasciitis, or compartment syndrome. Osteomyelitis management involves surgical resection of infected bone combined with four to six weeks of targeted antibiotic therapy.
Revascularization
Revascularization is indicated when ischemia contributes to wound non-healing, particularly in patients with WIfI ischemia grades 2 or 3. Angiosome-directed revascularization targets the artery supplying the wound territory to improve healing outcomes. The choice between endovascular and open bypass procedures depends on the patient's vascular anatomy, conduit availability, and comorbidities. Pedal bypass using autogenous vein remains a durable option for tibial occlusive disease.
Wound Management
Offloading is the single most important intervention for neuropathic plantar ulcers and can be achieved through total contact casting, irremovable walkers, or therapeutic footwear. Sharp debridement of callus and non-viable tissue is essential to promote healing. Maintaining a moist wound environment with appropriate dressings supports tissue repair. Negative pressure wound therapy (NPWT) accelerates granulation tissue formation. Advanced therapies such as skin substitutes, growth factors, and hyperbaric oxygen therapy may be considered for refractory wounds.
Glycemic Optimization
During active wound healing, the target HbA1c is less than 8%, balancing glycemic control while avoiding hypoglycemia. Perioperative insulin management protocols are important to maintain stable glucose levels. Nutritional optimization with adequate protein intake, exceeding 1.2 grams per kilogram per day, supports tissue repair and immune function.
Prevention
Prevention strategies include annual comprehensive foot examinations for all diabetic patients. Risk-stratified surveillance is necessary, with more frequent assessments for patients who have neuropathy, deformity, or prior ulceration. Therapeutic footwear with custom insoles is recommended for patients at high risk. Patient education emphasizes daily foot inspection, skin care, and avoidance of thermal and mechanical injury. Smoking cessation and cardiovascular risk reduction are also critical components of prevention.
Key Clinical Pearls
The diabetic foot is uniquely vulnerable due to the combined effects of neuropathy, peripheral arterial disease, and immunopathy, all of which must be addressed to achieve successful limb preservation. A positive probe-to-bone test in the setting of a diabetic foot ulcer is highly predictive of underlying osteomyelitis. Offloading remains the cornerstone of managing neuropathic ulcers but is frequently underutilized in clinical practice. Angiosome-directed revascularization has the potential to improve wound healing outcomes in patients with chronic limb-threatening ischemia and tissue loss. Multidisciplinary limb preservation programs have demonstrated significant reductions in major amputation rates, ranging from 35% to 50%.
References
- Armstrong DG, Boulton AJM, Bus SA. "Diabetic foot ulcers and their recurrence." N Engl J Med. 2017;376(24):2367-2375.
- Defined, Defined, et al. "IWGDF guidelines on the prevention and management of diabetic foot disease." Diabetes Metab Res Rev. 2020;36(Suppl 1):e3269.
- Defined, Defined, et al. "Multidisciplinary approach to the diabetic foot reduces amputation rates." Br J Surg. 2012;99(10):1388-1395.
- Defined, Defined, et al. "Angiosome-directed revascularization in critical limb ischemia." J Vasc Surg. 2013;57(4):974-981.